Mode
Text Size
Log in / Sign up
Phase 4 Completed N=99 Randomized Quadruple-blind Supportive Care

A Randomized Controlled Trial of Oral Acetaminophen for Analgesic Control After Transvaginal Oocyte Retrieval

Source: ClinicalTrials.gov NCT02418182 ↗
Enrolled (actual)
99
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcomePrimary: Median of Cumulative Pain Scores Up to 60 Minutes Post Procedure — 2; 2 score on a scale
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

Current standard of care is no pretreatment medications before the egg retrieval, and the investigators would like to evaluate if preoperative Tylenol improves procedure and post procedure pain control over the current practice (no pre-treatment). Specifically, this study will compare Tylenol with a placebo when given before retrieval procedures. The investigators believe that if Tylenol can offer better analgesic relief than no pretreatment medications, then it may reduce the amount of narcotics needed by patients during and after the procedure and contribute to better patient satisfaction. . This study will enroll 100 participants all from University of Alabama at Birmingham (UAB).

Outcome Measures

OutcomeResultp-value
PRIMARY
Median of Cumulative Pain Scores Up to 60 Minutes Post Procedure
2; 2
PRIMARY
Median of Cumulative Pain Scores Up to 24 Hours Post Procedure
1; 2
SECONDARY
Number of Participants With Use of Analgesics up to 60 Minutes Post Procedure
11; 18
SECONDARY
Number of Participants With Use of Analgesics in the First 24 Hours After Discharge
25; 27

Eligibility Criteria

Inclusion Criteria

  • English Speaking
  • Undergoing Transvaginal Oocyte Retrieval Procedure

Exclusion Criteria

  • Acetaminophen allergy
  • Opioid dependency
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02418182). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search